BioCryst Pharmaceuticals
BCRXBioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at BioCryst Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 12/22/2025 | Sell | Barnes, Alane P. | Chief Legal Officer | $7.7 | $166,563 |
| 12/15/2025 | Sell | Barnes, Alane P. | Chief Legal Officer | $7.7 | $162,257 |
| 12/3/2025 | Sell | Barnes, Alane P. | Chief Legal Officer | $7.7 | $151,241 |
| 12/2/2025 | Sell | Barnes, Alane P. | Chief Legal Officer | $7.2 | $367,216 |
| 12/1/2025 | Sell | Barnes, Alane P. | Chief Legal Officer | $7.1 | $646,511 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)